about
Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.N-TerminaL PRO-BNP in Acute Coronary Syndrome Patients with ST Elevation Versus Non ST Elevation in Qassim Region of Saudi ArabiaNatriuretic peptide C receptor signalling in the heart and vasculature.A Comparison of Prognostic Value of the Levels of ProBNP and Troponin T in Patients with Acute Coronary Syndrome (ACS)The effects of short-term high-fat feeding on exercise capacity: multi-tissue transcriptome changes by RNA sequencing analysis.Prevention and treatment of no-reflow.Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future.BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes.Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.The effect of coronary angioplasty on plasma NT-proBNP level in patients with and without arterial hypertension.Perioperative plasma brain natriuretic peptide and cardiotrophin-1 in off-pump coronary artery bypass.cGMP Signaling in the Cardiovascular System-The Role of Compartmentation and Its Live Cell Imaging.Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction.
P2860
Q36295757-392189CE-FAA1-4C7D-B524-D0EB5627D6B5Q36350919-14C5BD6D-4CF0-44CC-AF76-22597D45861FQ36465441-0C32E554-03F5-4D34-8D07-DD21E1E4925FQ37002318-CF088A6B-9013-4B09-94B9-74F3A974D78AQ37279802-C75FD897-B44E-45DA-8B5D-507F68BA0D83Q37623005-C6BAAFDB-70F4-460D-8DC8-4C85359A541EQ37779094-9E3CE683-D034-4B76-A022-74ADD09F6226Q38247701-FFE721DD-1871-42F4-A09A-071285C88011Q38324210-2193DCA7-A557-42E9-AD39-AF7260D559A6Q41487694-75E98AA5-6B0C-4B22-9675-16854CBAEAD4Q44792502-74A11B1D-872C-4194-8713-8DD0638CDF49Q48463980-5BA1AD1B-8D79-422B-9CE4-01E883F4F31DQ49109702-4AC30293-996B-49D5-9EDD-7E6F70F94A59Q55004774-3B5D7806-9419-4743-BFE8-028F0439F78BQ55334799-5937A1E9-08F8-4D46-A2F6-09E4E15B7E4F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Natriuretic peptides and myocardial ischaemia.
@ast
Natriuretic peptides and myocardial ischaemia.
@en
type
label
Natriuretic peptides and myocardial ischaemia.
@ast
Natriuretic peptides and myocardial ischaemia.
@en
prefLabel
Natriuretic peptides and myocardial ischaemia.
@ast
Natriuretic peptides and myocardial ischaemia.
@en
P1476
Natriuretic peptides and myocardial ischaemia.
@en
P2093
Gary F Baxter
P2888
P356
10.1007/S00395-004-0458-7
P577
2004-01-23T00:00:00Z